Building U.S. Exposure
-
Upload
tmx-equicom -
Category
Documents
-
view
308 -
download
1
description
Transcript of Building U.S. Exposure
![Page 1: Building U.S. Exposure](https://reader035.fdocuments.in/reader035/viewer/2022081403/554c02f6b4c9058e098b4ea3/html5/thumbnails/1.jpg)
Building U.S. Exposure
![Page 2: Building U.S. Exposure](https://reader035.fdocuments.in/reader035/viewer/2022081403/554c02f6b4c9058e098b4ea3/html5/thumbnails/2.jpg)
What we hear
No one understands
my storyI am
undervalued
I can’t find buyers
I need access to more capital
![Page 3: Building U.S. Exposure](https://reader035.fdocuments.in/reader035/viewer/2022081403/554c02f6b4c9058e098b4ea3/html5/thumbnails/3.jpg)
$11 trillion in mutual fund assets
48% of global AUM
Canada = 2% of global mutual funds
U.S. Capital Markets
The world’s largest pool of capital is next door
![Page 4: Building U.S. Exposure](https://reader035.fdocuments.in/reader035/viewer/2022081403/554c02f6b4c9058e098b4ea3/html5/thumbnails/4.jpg)
Accessing the U.S.
Where do I start?
When is the right time to start?
Who do I call?
How much time will this take?
![Page 5: Building U.S. Exposure](https://reader035.fdocuments.in/reader035/viewer/2022081403/554c02f6b4c9058e098b4ea3/html5/thumbnails/5.jpg)
U.S. investors are active here
of all trading on the TSX is international
%40billion
$285of trading comes from the U.S.
![Page 6: Building U.S. Exposure](https://reader035.fdocuments.in/reader035/viewer/2022081403/554c02f6b4c9058e098b4ea3/html5/thumbnails/6.jpg)
What kind of profile do you have south of the border?
![Page 7: Building U.S. Exposure](https://reader035.fdocuments.in/reader035/viewer/2022081403/554c02f6b4c9058e098b4ea3/html5/thumbnails/7.jpg)
Attracting investment
SELLside
BUYSIDE
IR consultants
ISSUER
![Page 8: Building U.S. Exposure](https://reader035.fdocuments.in/reader035/viewer/2022081403/554c02f6b4c9058e098b4ea3/html5/thumbnails/8.jpg)
Specialization
general industry coverage niche specific
general industry coverage drill down specific
generalists industry specific
resources & everything else generalists, industry specific
& niche specific
Bankers
Analysts
Sales
Buy side
![Page 9: Building U.S. Exposure](https://reader035.fdocuments.in/reader035/viewer/2022081403/554c02f6b4c9058e098b4ea3/html5/thumbnails/9.jpg)
Retail brokers cannot proactively solicit clients to invest
Requires Blue Sky statute eligibility
S&P Corporation Records program
• 38 States, excluding CA and NY
What about retail?
•Social media•Traditional media channels
Ground upstrategy
![Page 10: Building U.S. Exposure](https://reader035.fdocuments.in/reader035/viewer/2022081403/554c02f6b4c9058e098b4ea3/html5/thumbnails/10.jpg)
Financial centers
San Francisco
Montreal
CalgaryVancouver
New York
BostonToronto
Chicago
Los Angeles
Minneapolis
Denver
MiamiHouston
![Page 11: Building U.S. Exposure](https://reader035.fdocuments.in/reader035/viewer/2022081403/554c02f6b4c9058e098b4ea3/html5/thumbnails/11.jpg)
Noel BrownManaging Director of Healthcare Investment Banking
Alger BoyerManaging Director of Institutional Sales & Trading
Jeff HooPrincipal, Lead Micro-cap Portfolio Manager and Senior Analyst
Panelists
![Page 12: Building U.S. Exposure](https://reader035.fdocuments.in/reader035/viewer/2022081403/554c02f6b4c9058e098b4ea3/html5/thumbnails/12.jpg)
How does the process of building your profile in the U.S. capital markets begin?
![Page 13: Building U.S. Exposure](https://reader035.fdocuments.in/reader035/viewer/2022081403/554c02f6b4c9058e098b4ea3/html5/thumbnails/13.jpg)
What is the most effective way for a Canadian issuer to gain the attention of U.S. investors?
![Page 14: Building U.S. Exposure](https://reader035.fdocuments.in/reader035/viewer/2022081403/554c02f6b4c9058e098b4ea3/html5/thumbnails/14.jpg)
When does it make sense for an issuer to try to gain the attention of U.S. investors?
![Page 15: Building U.S. Exposure](https://reader035.fdocuments.in/reader035/viewer/2022081403/554c02f6b4c9058e098b4ea3/html5/thumbnails/15.jpg)
What are the typical liquidity and market cap levels a U.S. investor needs to see for an
investment consideration?
![Page 16: Building U.S. Exposure](https://reader035.fdocuments.in/reader035/viewer/2022081403/554c02f6b4c9058e098b4ea3/html5/thumbnails/16.jpg)
Is a U.S. listing the answer to a Canadian issuers problems?
![Page 17: Building U.S. Exposure](https://reader035.fdocuments.in/reader035/viewer/2022081403/554c02f6b4c9058e098b4ea3/html5/thumbnails/17.jpg)
Is it possible to gain research coverage from a U.S. analyst without that listing?
![Page 18: Building U.S. Exposure](https://reader035.fdocuments.in/reader035/viewer/2022081403/554c02f6b4c9058e098b4ea3/html5/thumbnails/18.jpg)
How does the buy side differ in the U.S. versus Canada? Should I tailor my story to
the U.S. audience?
![Page 19: Building U.S. Exposure](https://reader035.fdocuments.in/reader035/viewer/2022081403/554c02f6b4c9058e098b4ea3/html5/thumbnails/19.jpg)
Questions?
![Page 20: Building U.S. Exposure](https://reader035.fdocuments.in/reader035/viewer/2022081403/554c02f6b4c9058e098b4ea3/html5/thumbnails/20.jpg)
Thank you!